Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)

  • Technology appraisal
  • TA678
  • Terminated:

History

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Notes